Meeting
2016 ASCO Annual Meeting
Development and validation of a new prognostic score on 4,646 patients with luminal-like breast cancer (BC) enrolled in 7 randomized prospective trials.
Authors
Caterina Fontanella
University Hospital, Udine, Italy
Caterina Fontanella , Bianca Lederer , Lucia Del Mastro , Carsten Denkert , Sabino De Placido , Claus Hanusch , Francesco Cognetti , Jens Bodo Huober , Michele De Laurentiis , Christian Jackisch , Giancarlo Bisagni , Sherko Kummel , Ornella Garrone , Andreas Schneeweiss , Filippo Montemurro , Michael Untch , Claudia Bighin , Gunter Von Minckwitz , Sibylle Loibl , Fabio Puglisi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—HER2/ER
Track
Breast Cancer
Sub Track
ER+
Citation
J Clin Oncol 34, 2016 (suppl; abstr 529)
DOI
10.1200/JCO.2016.34.15_suppl.529
Abstract #
529
Poster Bd #
17
Abstract Disclosures
Similar Posters
First Author: Caterina Fontanella
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Metronomic oral cyclophosphamide as maintenance therapy in metastatic pancreatic ductal adenocarcinoma.
First Author: Michele Reni
Poster
2022 ASCO Annual Meeting
The real-world experience of adjuvant docetaxel and cyclophosphamide (TC) chemotherapy in HER-2 negative breast cancer.
First Author: Danilo Giffoni M. M. Mata
Poster
2021 ASCO Annual Meeting
Survival time in urban center breast cancer patients with CNS metastasis with or without visceral metastasis.
First Author: Miriam Pearl Klahr